Anti-Toxoplasma gondii antibodies in haemodialysis patients

14Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Problem statement: In situations of immunodeficiency, Toxoplasma gondii emerges as a life-threatening infection. Toxoplasma gondii is transmitted parenterally, flourish in immunocompromised subjects and, most toxoplasma infections are asymptomatic. Studies have shown that there is a immunodeficiency in renal failure patient such as hemodialysis patients and these patients have a high risk for many infections. There is no evidence about toxoplasmosis in hemodialysis patients in Iran. Approach: In the present study, we aimed to investigate the prevalence of anti-T. gondii antibodies in hemodialysis patients with chronic renal failure. This case-control study was carried out on 44 hemodialysis patients and 44 healthy controls for the prevalence of anti-T. gondii antibodies by ELISA. Anti-IgG, IgM and IgA T. gondii antibodies positivity were found to be 26 (59.10%), 3 (6.80%) and 3 (6.80%) of the 44 hemodialysis patients, respectively and 16 (36.40%) of the 44 control subjects were Anti-IgG T. gondii antibodies positivity and all of control subjects were negative for Anti-IgM and IgA T. gondii antibodies. The difference between them was statistically significant (p = 0.032). In addition, an increase of the seropositivity rate was detected with increasing length of time on hemodialysis treatment, indicating a statistically significant difference between these 2 parameters (p<0.001). Results: These findings confirm a high prevalence of toxoplasma infection in hemodialysis patients and these patients are a risk group for toxoplasma infection. Results showed that 3 hemodialysis patients had an acute and active infection. Conclusion: Moreover, it is recommended that hemodialysis patients who are susceptible to toxoplasma infections should be identified by T. gondii IgG and IgM and/or IgA specific serological tests. Therefore, patients undergoing hemodialysis should be screened for toxoplasma before dialysis to prevent the dissemination of this infection through the hemodialysis procedure. © 2010 Science Publications.

References Powered by Scopus

Toxoplasmosis

2997Citations
N/AReaders
Get full text

Toxoplasma gondii: From animals to humans

2791Citations
N/AReaders
Get full text

Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropathological findings in 27 patients

398Citations
N/AReaders
Get full text

Cited by Powered by Scopus

A systematic review and meta-analysis of the prevalence of toxoplasmosis in hemodialysis patients in Iran

45Citations
N/AReaders
Get full text

Detection of toxoplasmosis in patients with end-stage renal disease by enzyme-linked immunosorbent assay and polymerase chain reaction methods

38Citations
N/AReaders
Get full text

Seroprevalence and risk factors of Toxoplasma gondii infection among Cancer and Hemodialysis Patients in southwest Iran

21Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Solhjoo, K., Jahromi, A. S., & Parnian-Rad, A. (2010). Anti-Toxoplasma gondii antibodies in haemodialysis patients. American Journal of Infectious Diseases, 6(1), 13–17. https://doi.org/10.3844/ajidsp.2010.13.17

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

57%

Researcher 2

29%

Professor / Associate Prof. 1

14%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 2

40%

Medicine and Dentistry 1

20%

Pharmacology, Toxicology and Pharmaceut... 1

20%

Arts and Humanities 1

20%

Save time finding and organizing research with Mendeley

Sign up for free